CDSCO Panel grants AstraZeneca's proposal for withdrawing specific Indications of Olaparib Tablets Dr. Divya Colin11 April 2024 6:00 PM ISTNew Delhi: Reviewing the Clinical evidence presented by drug major AstraZeneca, the Subject Expert Committee (SEC) functional under the Central Drug...
European Commission approves Merck Keytruda plus Chemotherapy for lung cancer Ruchika Sharma1 April 2024 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
Combined PET-MRI scan could improve treatment for patients with early breast cancer: Study Dr. Kamal Kant Kohli24 March 2024 8:00 PM ISTUsing a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial...
Understanding Chemotherapy: A Comprehensive Guide to Treatment Plans - Dr Philip George Kuttikat Dr Philip George Kuttikat23 March 2024 11:51 AM ISTChemotherapy is a cornerstone in the battle against cancer, serving as a vital treatment modality. This multifaceted strategy employs potent drugs to...
Takeda bags accelerated USFDA nod for Iclusig with chemotherapy in adult patients with newly diagnosed Ph+ ALL Ruchika Sharma22 March 2024 11:57 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin17 March 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study Dr. Divya Colin16 March 2024 4:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
USFDA nod to JnJ for Rybrevant, Chemotherapy combo for lung cancer treatment Anshika Mishra4 March 2024 5:09 PM ISTJohnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Health Bulletin 04/ March/ 2024 Anshika Mishra4 March 2024 4:44 PM ISTHere the top health news for the day :Lady hardinge medical college to introduce new DNB and FNB courses soon Bringing good news to the postgraduate...
Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment Ruchika Sharma2 March 2024 2:33 PM ISTRaritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Merck gets positive EMA Committee opinion for Keytruda, chemotherapy combo for Resectable non-small cell lung cancer Ruchika Sharma26 Feb 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review Ruchika Sharma22 Feb 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
